{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ballouz T"],"funding":["Department of Health, Canton of Zurich, Switzerland","University of Zurich (UZH) Foundation","Swiss School of Public Health","University of Zurich (UZH) Postdoc Grant","H2020 Marie Skłodowska-Curie Actions","Swiss Federal Office of Public Health"],"pagination":["e0281429"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9946205"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["18(2)"],"pubmed_abstract":["<h4>Background</h4>Post COVID-19 condition (PCC) is an important complication of SARS-CoV-2 infection, affecting millions worldwide. This study aimed to evaluate the prevalence and severity of post COVID-19 condition (PCC) with novel SARS-CoV-2 variants and after prior vaccination.<h4>Methods</h4>We used pooled data from 1350 SARS-CoV-2-infected individuals from two representative population-based cohorts in Switzerland, diagnosed between Aug 5, 2020, and Feb 25, 2022. We descriptively analysed the prevalence and severity of PCC, defined as the presence and frequency of PCC-related symptoms six months after infection, among vaccinated and non-vaccinated individuals infected with Wildtype, Delta, and Omicron SARS-CoV-2. We used multivariable logistic regression models to assess the associat"],"journal":["PloS one"],"pubmed_title":["Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts."],"pmcid":["PMC9946205"],"funding_grant_id":["FK-22-053","801076"],"pubmed_authors":["Menges D","Albanese E","Frei A","Kaufmann M","Fehr JS","Puhan MA","von Wyl V","Amati R","Ballouz T"],"additional_accession":[]},"is_claimable":false,"name":"Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.","description":"<h4>Background</h4>Post COVID-19 condition (PCC) is an important complication of SARS-CoV-2 infection, affecting millions worldwide. This study aimed to evaluate the prevalence and severity of post COVID-19 condition (PCC) with novel SARS-CoV-2 variants and after prior vaccination.<h4>Methods</h4>We used pooled data from 1350 SARS-CoV-2-infected individuals from two representative population-based cohorts in Switzerland, diagnosed between Aug 5, 2020, and Feb 25, 2022. We descriptively analysed the prevalence and severity of PCC, defined as the presence and frequency of PCC-related symptoms six months after infection, among vaccinated and non-vaccinated individuals infected with Wildtype, Delta, and Omicron SARS-CoV-2. We used multivariable logistic regression models to assess the associat","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-04T22:38:48.807Z","creation":"2025-04-04T22:38:48.807Z"},"accession":"S-EPMC9946205","cross_references":{"pubmed":["36812215"],"doi":["10.1371/journal.pone.0281429"]}}